FLUAD QUADRIVALENT
STN: 125510
Proper Name: Influenza Vaccine, Adjuvanted
Tradename: FLUAD QUADRIVALENT
Manufacturer: Seqirus, Inc.
Indications:
- For active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and types B contained in the vaccine
Product Information
Supporting Documents
- June 30, 2023 Approval Letter - FLUAD QUADRIVALENT
- February 24, 2023 Approval Letter - FLUAD QUADRIVALENT
- July 1, 2022 Approval Letter - FLUAD QUADRIVALENT
- July 2, 2021 Approval Letter - FLUAD
- Statistical Review - FLUAD and FLUAD Quadrivalent
- Clinical Review - FLUAD and FLUAD Quadrivalent
- December 4, 2020 Approval Letter - FLUAD QUADRIVALENT
- October 28, 2020 Approval Letter - Fluad and Fluad Quadrivalent
- July 2, 2020 Approval Letter Fluad and Fluad Quadrivalent
- February 21, 2020 Approval Letter - FLUAD QUADRIVALENT
- February 20, 2020 Clinical Review - FLUAD QUADRIVALENT
- Statistical Review - FLUAD QUADRIVALENT